Cleared Traditional

K810810 - AMICON ULTRAFILTRATION MEMBRANES CMII
(FDA 510(k) Clearance)

K810810 · Amicon, Inc. · Chemistry
Apr 1981
Decision
24d
Days
Class 2
Risk

K810810 is an FDA 510(k) clearance for the AMICON ULTRAFILTRATION MEMBRANES CMII. This device is classified as a System, Test, Carcinoembryonic Antigen (Class II — Special Controls, product code DHX).

Submitted by Amicon, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 17, 1981, 24 days after receiving the submission on March 24, 1981.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K810810 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 24, 1981
Decision Date April 17, 1981
Days to Decision 24 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary

Device Classification

Product Code DHX — System, Test, Carcinoembryonic Antigen
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — DHX System, Test, Carcinoembryonic Antigen

All 27
Access CEA
K223921 · Beckman Coulter, Inc. · Sep 2023
VITROS Immunodiagnostic Products CEA Reagent Pack
K231517 · Ortho-Clinical Diagnostics · Aug 2023
ADVIA Centaur CEA Assay
K200215 · Siemens Healthcare Disgnostics, Inc. · Apr 2020
OLYMPUS CEA - CARCINOEMBRYONIC ANTIGEN
K081615 · Olympus America, Inc. · Mar 2009
VIDAS CEA (S) ASSAY
K080194 · bioMerieux, Inc. · Oct 2008
DIMENSION VISTA CARCINOEMBRYONIC ANTIGEN FLEX REAGENT CARTRIDGE (CEA)
K071603 · Dade Behring, Inc. · Jun 2008